CellaVision AB
OTC:CLVSF

Watchlist Manager
CellaVision AB Logo
CellaVision AB
OTC:CLVSF
Watchlist
Price: 17.3 USD 1.76%
Market Cap: 412.6m USD

Net Margin

20.2%
Current
Improving
by 1.2%
vs 3-y average of 19%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
20.2%
=
Net Income
kr151.4m
/
Revenue
kr748.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
20.2%
=
Net Income
$151.4m
/
Revenue
kr748.5m

Peer Comparison

Country Company Market Cap Net
Margin
SE
CellaVision AB
STO:CEVI
3.8B SEK
Loading...
US
Abbott Laboratories
NYSE:ABT
191.2B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
138B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.7B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
38.4B USD
Loading...
No Stocks Found

Market Distribution

Higher than 86% of companies in Sweden
Percentile
86th
Based on 2 084 companies
86th percentile
20.2%
Low
-5 565 412.8% — -5.3%
Typical Range
-5.3% — 7.5%
High
7.5% — 12 228%
Distribution Statistics
Sweden
Min -5 565 412.8%
30th Percentile -5.3%
Median 3%
70th Percentile 7.5%
Max 12 228%

CellaVision AB
Glance View

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CLVSF Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
20.2%
=
Net Income
kr151.4m
/
Revenue
kr748.5m
What is CellaVision AB's current Net Margin?

The current Net Margin for CellaVision AB is 20.2%, which is above its 3-year median of 19%.

How has Net Margin changed over time?

Over the last 3 years, CellaVision AB’s Net Margin has increased from 19.3% to 20.2%. During this period, it reached a low of 16% on Jun 30, 2023 and a high of 20.4% on Sep 30, 2024.

Back to Top